Perspective Therapeutics Welcomes Juan Graham As Chief Financial Officer

Perspective Therapeutics, Inc. is a radiopharmaceutical company advancing innovative cancer treatments. The firm has announced the appointment of Juan Graham as its new Chief Financial Officer (CFO), effective January 6, 2025. As he continues with his contributions to the company, Jonathan Hunt will no longer be serving as a CFO but will transition to a Chief Accounting Officer (CAO) role.

Thijs Spoor, Perspective's CEO, said in a statement, "In less than 18 months, Perspective has delivered initial clinical data for two new potential medicines based on its next-generation targeted radiopharmaceutical technology platform and is poised to do more in the next 18 months while building the manufacturing infrastructure to enable broader availability of our medicines.” 

He also said, “As we progress with our platform development, we are strengthening the finance function to support our growth by adding Juan as our CFO and having Jonathan remain in the role of CAO. Juan's strategic mindset and financial leadership to deliver our vision will be valuable to the executive team. I would also like to thank Jonathan for his continuing commitment and dedication, which have contributed greatly to our achievements."

Juan Graham brings nearly 25 years of global finance experience in life sciences to his new position. Before joining Perspective Therapeutics, he served as CFO at FibroGen, overseeing global financial operations, leading capital allocation strategies, and supporting key licensing and partnership initiatives. His career includes nearly two decades at Johnson & Johnson, where he held various senior finance and business development roles across different divisions and global locations.

Mr. Graham commented, "I am excited to join Perspective at this critical point in the Company's development, as we are working to deliver further progress on two clinical programs, initial data on a third clinical program, and advance multiple new programs into the clinic. I look forward to helping propel the Company's growth and scale in the coming years."

Mr. Graham holds an MBA from McGill University and a bachelor's degree in business from Tec de Monterrey (ITESM). His extensive expertise is expected to strengthen Perspective's financial strategy as the company continues to push forward with its mission to develop innovative cancer therapies.